HIV DNA Vaccine Elicits Strong T Cell Responses
Author Information
Author(s): Rosa Daniela Santoro, Susan Pereira Ribeiro, Rafael Ribeiro Almeida, Eliane Conti Mairena, Edilberto Postól, Jorge Kalil, Edecio Cunha-Neto
Primary Institution: University of São Paulo School of Medicine, São Paulo, Brazil
Hypothesis
Can a DNA vaccine encoding multiple HIV CD4 epitopes induce strong T cell responses?
Conclusion
The HIVBr18 vaccine induced broad, polyfunctional, and long-lived CD4+ and CD8+ T cell responses in mice.
Supporting Evidence
- The vaccine induced high-magnitude, broad CD4+/CD8+ T cell responses.
- 8 out of 18 vaccine-encoded peptides were recognized by T cells.
- Immunization generated long-lived central and effector memory CD4+ T cells.
Takeaway
The study shows that a new HIV vaccine can make the body's immune system create strong defenses against the virus.
Methodology
BALB/c mice were immunized with the HIVBr18 DNA vaccine, and T cell responses were measured using ELISPOT and flow cytometry.
Limitations
The study was conducted in mice, and results may not directly translate to humans.
Participant Demographics
Female BALB/c mice, aged 6-8 weeks.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website